{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:28:04Z","timestamp":1714177684070},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"DOI":"10.7759\/cureus.59068","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T14:53:42Z","timestamp":1714143222000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical Guillain-Barr\u00e9 Syndrome in a Pediatric Patient With a Preceding Non-COVID-19 Coronavirus Infection: A Case Report"],"prefix":"10.7759","author":[{"given":"Navjot","family":"Azad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Marzullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Guillain-Barre Syndrome","author":"Nguyen TP","year":"2023","unstructured":"Nguyen TP, Taylor RS. Guillain-Barre Syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg B","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014, 10:469-82. 10.1038\/nrneurol.2014.121","journal-title":"Nat Rev Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214222","article-title":"Triggers of Guillain-Barr\u00e9 syndrome: Campylobacter jejuni predominates","volume":"23","author":"Finsterer J","year":"2022","unstructured":"Finsterer J. Triggers of Guillain-Barr\u00e9 syndrome: Campylobacter jejuni predominates. Int J Mol Sci. 2022, 23:10.3390\/ijms232214222","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke C","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria. Brain. 2014, 137:33-43. 10.1093\/brain\/awt285","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1084\/jem.178.5.1771","article-title":"A bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure","volume":"178","author":"Yuki N","year":"1993","unstructured":"Yuki N, Taki T, Inagaki F, et al.. A bacterium lipopolysaccharide that elicits Guillain-Barr\u00e9 syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993, 178:1771-5. 10.1084\/jem.178.5.1771","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37338","article-title":"The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice","volume":"119","author":"Greenshields KN","year":"2009","unstructured":"Greenshields KN, Halstead SK, Zitman FM, et al.. The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J Clin Invest. 2009, 119:595-610. 10.1172\/JCI37338","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki K","year":"2007","unstructured":"Susuki K, Rasband MN, Tohyama K, et al.. Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci. 2007, 27:3956-67. 10.1523\/JNEUROSCI.4401-06.2007","journal-title":"J Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2014.01.007","article-title":"Early electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy: a retrospective study of 58 patients","volume":"125","author":"Chanson JB","year":"2014","unstructured":"Chanson JB, Echaniz-Laguna A. Early electrodiagnostic abnormalities in acute inflammatory demyelinating polyneuropathy: a retrospective study of 58 patients. Clin Neurophysiol. 2014, 125:1900-5. 10.1016\/j.clinph.2014.01.007","journal-title":"Clin Neurophysiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8027.2011.00338.x","article-title":"Very early electrodiagnostic findings in Guillain-Barr\u00e9 syndrome","volume":"16","author":"Albert\u00ed MA","year":"2011","unstructured":"Albert\u00ed MA, Alentorn A, Mart\u00ednez-Yelamos S, Mart\u00ednez-Matos JA, Povedano M, Montero J, Casasnovas C. Very early electrodiagnostic findings in Guillain-Barr\u00e9 syndrome. J Peripher Nerv Syst. 2011, 16:136-42. 10.1111\/j.1529-8027.2011.00338.x","journal-title":"J Peripher Nerv Syst"},{"key":"ref10","article-title":"Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes. 1916. [Article in French]","volume":"150","author":"Guillain G","year":"1999","unstructured":"Guillain G, Barr\u00e9 JA, Strohl A. Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes. 1916. [Article in French]. Ann Med Interne (Paris). 1999, 150:24-32.","journal-title":"Ann Med Interne (Paris)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury AK","year":"1990","unstructured":"Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome. Ann Neurol. 1990, 27:21-4. 10.1002\/ana.410270707","journal-title":"Ann Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie MM","year":"2013","unstructured":"Dimachkie MM, Barohn RJ. Guillain-Barr\u00e9 syndrome and variants. Neurol Clin. 2013, 31:491-510. 10.1016\/j.ncl.2013.01.005","journal-title":"Neurol Clin"},{"key":"ref13","article-title":"Atypical findings of Guillain-Barr\u00e9 syndrome in children","volume":"6","author":"Karimzadeh P","year":"2012","unstructured":"Karimzadeh P, Bakhshandeh Bali MK, Nasehi MM, Taheri Otaghsara SM, Ghofrani M. Atypical findings of Guillain-Barr\u00e9 syndrome in children. Iran J Child Neurol. 2012, 6:17-22.","journal-title":"Iran J Child Neurol"},{"key":"ref14","article-title":"Clinical features and outcome of Guillain-Barr\u00e9 syndrome in children","volume":"12","author":"Nasiri J","year":"2018","unstructured":"Nasiri J, Ghazavi M, Yaghini O, Chaldavi M. Clinical features and outcome of Guillain-Barr\u00e9 syndrome in children. Iran J Child Neurol. 2018, 12:49-57.","journal-title":"Iran J Child Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000119","article-title":"Human immunoglobulin versus plasmapheresis in Guillain-Barre syndrome and myasthenia gravis: a meta-analysis","volume":"18","author":"Ortiz-Salas P","year":"2016","unstructured":"Ortiz-Salas P, Velez-Van-Meerbeke A, Galvis-Gomez CA, Rodriguez Q JH. Human immunoglobulin versus plasmapheresis in Guillain-Barre syndrome and myasthenia gravis: a meta-analysis. J Clin Neuromuscul Dis. 2016, 18:1-11. 10.1097\/CND.0000000000000119","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"van der Mech\u00e9 FG","year":"1992","unstructured":"van der Mech\u00e9 FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group. N Engl J Med. 1992, 326:1123-9. 10.1056\/NEJM199204233261705","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244692-atypical-guillain-barr-syndrome-in-a-pediatric-patient-with-a-preceding-non-covid-19-coronavirus-infection-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T14:53:46Z","timestamp":1714143226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244692-atypical-guillain-barr-syndrome-in-a-pediatric-patient-with-a-preceding-non-covid-19-coronavirus-infection-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.59068","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}